About RAL Diagnostics
RAL Diagnostics is a company based in Bordeaux (France) founded in 1916 was acquired by Cellavision in September 2019. RAL Diagnostics operates in a competitive market with competitors including Cepheid, Beckman Coulter, Blackrock Neurotech, Bruker and Esco Lifesciences, among others.
- Headquarter Bordeaux, France
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ral-diagnostics.fr
- Social LinkedIn X
- Acquired by Cellavision (Sep 2019)
- Investors
- Acquired byCellavision
(Sep 2019)
Investors in RAL Diagnostics
RAL Diagnostics has secured backing from 1 investor. Prominent investors backing the company include Cellavision.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Solutions for digital microscopy. | 1994 | cellavision.com | Lund, Sweden |
Investor details for RAL Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of RAL Diagnostics
1 people are tracked at RAL Diagnostics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Frederic Imbs | CEO | Leadership |
Complete people profiles for RAL Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of RAL Diagnostics
2 dated milestones of RAL Diagnostics across 103 years, from founding to its latest funding, stage changes and deals.
- Founded RAL Diagnostics is founded.
- Exit Acquired by Cellavision.
Competitors of RAL Diagnostics
RAL Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Beckman Coulter, Blackrock Neurotech, Bruker and Esco Lifesciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cepheid.com | 1996 | Sunnyvale, United States | $19.1M | 1,299 | Developer of molecular diagnostic testing solutions | |
| beckman.com | 1935 | Brea, United States | – | – | Provider of products for biomedical testing for R&D, diagnostic and commercial applications | |
| blackrockneurotech.com | 2008 | Salt Lake, United States | $22.37M | 127 | Medical devices for neurological therapies are developed. | |
| bruker.com | 1960 | United States | – | 9,707 | Diversified research instrument systems are manufactured and supplied. | |
| escolifesciences.com | 1978 | Singapore | $400M | – | Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools | |
| agilent.com | 1995 | Santa Clara, United States | – | 121 | Diversified instruments are developed for scientific and laboratory management. | |
| unchainedlabs.com | 2015 | Pleasanton, United States | $111M | – | Multiplex protein stability platform for biologics is developed. | |
| waters.com | 1958 | Milford, United States | – | 9,341 | Provider of laboratory management system for researchers and clinicians | |
| aicompanies.com | 1955 | Norwood, United States | – | – | Manufacturer of Laboratory equipment | |
| sartorius.com | 1870 | Gottingen, Germany | – | 566 | Laboratory and biopharmaceutical equipment is developed for production processes. |
Detailed competitors of RAL Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of RAL Diagnostics
Websites that share an audience with RAL Diagnostics (ral-diagnostics.fr).
Websites whose visitors overlap most with RAL Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
sysmex.fr | sysmex.fr | 100% | – | #1,928,300 | – |
atomscientific.com | atomscientific.com | 56% | – | #1,181,230 | – |
Similar companies to RAL Diagnostics
10 companies that operate in the same segment as RAL Diagnostics (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RAL Diagnostics
RAL Diagnostics was founded in 1916.
RAL Diagnostics is headquartered in Bordeaux, France.
Frederic Imbs is the current CEO of RAL Diagnostics.
RAL Diagnostics manufactures and markets staining solution, reagents, and instruments for intelligent microscopy. The company offers dyes to identify cell and tissue morphology, parasites and bacteria reagents for hematology, bacteriology, parasitology, mycology, cytology, and histology, Fluo-Track (fluorescein) used as a tracer (sanitation, location of liquid paths) and the VB RAL kit (methylene blue) to determine purity ranges, relevant dyes for animal health, Semi-automated staining system,LED illuminator, and Automated staining system.
RAL Diagnostics's top competitors include Cepheid, Blackrock Neurotech and Agilent.
RAL Diagnostics has 1 investor. Key investors include Cellavision.
Yes. RAL Diagnostics was acquired by Cellavision in September 2019.